Cuatrecasas, through its Bogotá office, has advised Fondo Ashmore Andino III and Ashmore Andean Fund III on the acquisition of 85% of the shares of Sociedad de Oncología y Hematología del Cesar (SOHEC), which
Cuatrecasas, through its Bogotá office, has advised Fondo Ashmore Andino III and Ashmore Andean Fund III on the acquisition of 85% of the shares of Sociedad de Oncología y Hematología del Cesar (SOHEC), which